AdelaideRobbMD

Child & Adolescent Psychiatry, Psychopharmacology

Professor, Distinguished Endowed Chair, Psychiatry & Behavioral Science, G Washington University School of Medicine & Hlth Sci

Dr. Robb is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
111 Michigan Ave NW
Washington, DC 20010
Phone+1 202-884-5386

Fax+1 202-476-5898

Children's National Hospital/George Washington UniversityFellowship, Child and Adolescent Psychiatry, 1994 - 1996
Johns Hopkins UniversityResidency, Psychiatry, 1987 - 1990
Johns Hopkins University School of MedicineClass of 1987

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® Start of enrollment: 2014 Jun 01
Terminated
Phase 2, Phase 3
Roles: Principal Investigator, Contact

PubMed

25 citations
Adjunctive Maintenance Lamotrigine for Pediatric Bipolar i Disorder: A Placebo-Controlled, Randomized Withdrawal Study
Robert L. Findling, Kiki D. Chang, Adelaide S. Robb, Vicki J. Foster, Joseph P. Horrigan
Journal of the American Academy of Child and Adolescent Psychiatry. 2015-12-01
25 citations
Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies.
Antonio Y. Hardan, Robert L. Hendren, Michael G. Aman, Adelaide S. Robb, Raun D. Melmed
Autism. 2019-04-26
32 citations
Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.
Robert L. Findling, Adelaide S. Robb, Anjana Bose
Journal of Child and Adolescent Psychopharmacology. 2013-09-16

Lectures

2013 Psychopharmacology Update Institute
American Academy of Child and Adolescent Psychiatry(AACAP), Washington, Dist Of Col - 1/25/2013